AzTrials
AzTrials

Dentin SensitivityPhase 4NCT02461030

Efficacy of Two Oral Hygiene Regimens in the Reduction of Dentin Hypersensitivity After Periodontal Treatment

A Phase 4 study testing In-office and at home Colgate sensitive pro-relief - CSPR, In-office Villevie® prophy paste + Colgate Toothpaste and Non-surgical periodontal treatment in people with Dentin Sensitivity and Periodontal Diseases, run by University of Campinas, Brazil at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aim is to determine the efficacy of two Oral Hygiene Regimens in the reduction of dentin hypersensitivity on subjects undergoing non-surgical periodontal treatment, over a period of 8 weeks. Read more about this study

Who is it for?
Ages 30 to 75 years
Conditions the study is for
Dentin Sensitivity, Periodontal Diseases
What is being tested?
In-office and at home Colgate sensitive pro-relief - CSPR, In-office Villevie® prophy paste + Colgate Toothpaste and Non-surgical periodontal treatment
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteBrazil
Study dates
Aug 2014to Dec 2014
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Males and females, between 30-75 years of age;
  • Availability for the duration of the study;
  • Individuals diagnosed with moderate chronic periodontal disease (4-5 mm loss of clinical attachment, according to AAP), and indication for non-surgical periodontal therapy;
  • Diagnosis, by air blast, of at least two (2) hypersensitive teeth with a score of 2 or 3 on the Schiff Cold Air Sensitivity Scale;
  • Subjects in good general health and no allergies to products that are being tested.

Who cannot join

  • Oral pathology, chronic disease, or a history of allergy to testing products;
  • Qualifying sensitive teeth with extensive/defective restorations, pulpitis, caries, cracked enamel, or these teeth used as abutments for removable partial dentures;
  • Subject using anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory medication or daily analgesics within one month prior to the start of the study or scheduled to start such intake during the course of the study;
  • Subject regularly using desensitizing toothpaste;
  • Current smokers;
  • Subject pregnant or breast feeding;
  • Allergies to oral care products, personal care consumer products, or their ingredients.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Piracicaba Dental School, State University of Campinas

    Piracicaba, São Paulo, 13414-903

Other trials in Brazil

About this study

Official title: An 8-Week Clinical Study to Evaluate the Efficacy of Two Oral Hygiene Regimens in the Reduction of Dentin Hypersensitivity After Non-surgical Periodontal Treatment: Randomized Clinical Trial

This study aim is to determine the efficacy of two Oral Hygiene Regimens in the reduction of dentin hypersensitivity on subjects undergoing non-surgical periodontal treatment, over a period of 8 weeks.

Read the detailed description

This study aim was to determine the efficacy of two Oral Hygiene Regimens in the reduction of dentin hypersensitivity on subjects undergoing non-surgical periodontal treatment, over a period of 8 weeks. The study was conducted in Piracicaba Dental School, Piracicaba, São Paulo, Brazil, using a double-blind/two treatment design. Sixty subjects (30 per group) that meet the inclusion and exclusion criteria were assigned to the groups: Test group (Non-surgical periodontal treatment + In-office application of Colgate Sensitive Pro-Relief - CSPR + tooth brushing with at home CSPR toothpaste) and Control group (Non-surgical periodontal treatment + In-office application of a fluoride-free prophy paste + tooth brushing with a Colgate Cavity Protection Toothpaste). Air blast sensitivity assessments were used to compare the efficacy of the two approaches using both the Schiff scale. The sensitivity parameters were measured at baseline, 1, 4 and 8 weeks.

Being tested
In-office and at home Colgate sensitive pro-relief - CSPR, In-office Villevie® prophy paste + Colgate Toothpaste, Non-surgical periodontal treatment
Keywords
Dentin hypersensitivity, Periodontal disease, Arginine
Medical subject headings
Dentin Sensitivity, Periodontal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • In-office and at home Colgate sensitive pro-relief - CSPRDrug

    Also called CSPR

    Prophylaxis with rubber cup using In-office Colgate sensitive pro-relief (CSPR), after non-surgical periodontal therapy, and tooth brushing with at home CSPR toothpaste.

  • In-office Villevie® prophy paste + Colgate ToothpasteDrug

    Also called Colgate Cavity Protection Toohtpaste

    Prophylaxis with rubber cup using In-office Villevie® (fluoride-free) prophy paste + Colgate Toothpaste, after non-surgical periodontal therapy.

  • Non-surgical periodontal treatmentProcedure or surgery

    Full-mouth debridment, scaling and root planing with ultrasonic/hand instruments

Study groups in NCT02461030
Study groupRoleWhat they receive
CSPR + NS treatmentExperimentalIn-office and at home Colgate sensitive pro-relief - CSPR Intervention: Non-surgical periodontal treatment (full-mouth debridement, scaling and root planing with ultrasonic/hand instruments) associated with In-office application of Colgate Sensitive Pro-Relief (CSPR) + tooth brushing with at home CSPR toothpaste during 8 weeks.
Receives: Drug: In-office and at home Colgate sensitive pro-relief - CSPR; Procedure: Non-surgical periodontal treatment
Villevie® + NS treatmentPlacebo comparatorIn-office Villevie® prophy paste + Colgate Toothpaste Treatment: In-office application of a Villevie® (fluoride-free) prophy paste + tooth brushing with a Colgate Cavity Protection Toothpaste during 8 weeks, after non-surgical periodontal treatment. (Full-mouth debridment/ Scaling and root planing with ultrasonic/hand instruments)
Receives: Drug: In-office Villevie® prophy paste + Colgate Toothpaste; Procedure: Non-surgical periodontal treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dentin hypersensitivity reduction

    Air blast sensitivity assessments using Schiff scale at baseline and up to 8 weeks after non-surgical periodontal treatment.

    Measured: Baseline, 8 weeks

Secondary outcomes (1)
  1. Probing depth reduction

    Full-mouth probing, at baseline and up to 8 weeks after non-surgical periodontal treatment.

    Measured: Baseline, 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jun 2015 (estimated)
  2. Study startAug 2014
  3. Primary completionNov 2014
  4. Study completionDec 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02461030
Sponsor's protocol ID
058/2013
Status last verified
May 2015
First submitted
28 May 2015
Last updated
3 Jun 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing In-office and at home Colgate sensitive pro-relief - CSPR, In-office Villevie® prophy paste + Colgate Toothpaste and Non-surgical periodontal treatment in people with Dentin Sensitivity and Periodontal Diseases, run by University of Campinas, Brazil at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dentin hypersensitivity reduction (time frame: Baseline, 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in